Skip to main content
Premium Trial:

Request an Annual Quote

Synthetic Genomics, Avoca Ink Deal for Natural Astaxanthin

NEW YORK (GenomeWeb) – Avoca and Synthetic Genomics today announced a supply agreement to extract and commercialize natural astaxanthin from algae strains developed by SGI.

The agreement also gives Avoca the exclusive rights to sell in North America products based on SGI-produced astaxanthin. Avoca's parent firm, Pharmachem Laboratories, will market and sell the products.

Natural astaxanthin is a supplement with health benefits associated with its antioxidant and anti-inflammatory properties, Avoca said. However, the difficult nature of producing the supplement has meant supplies of it have fallen short of demand.

SGI has developed a production process for natural astaxanthin from a phototropic source and has shown capabilities to manufacture it on a commercial scale. Products covered by the deal are being developed by SGI's Genovia Bio business unit, which has responsibility for developing and commercializing algal-based food, chemical, and fuel products.

Financial and other terms of the deal were not disclosed.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.